Aviceda aims to raise $200M; Nerviano gets back rights to PARP1 inhibitor
In the latest news, Aviceda Therapeutics, a biotech company based in Boston, is looking to raise $200 million in financing....
In the latest news, Aviceda Therapeutics, a biotech company based in Boston, is looking to raise $200 million in financing....
When Donald Trump pulled off a surprising victory on November 8, the stock market initially took a hit. However, in...
Insider trading is a serious offense that can have major consequences for individuals and companies involved. The Securities and Exchange...
There's been a lot of buzz lately about the Securities and Exchange Commission (SEC) and its role in the financial...
Cryptocurrency pumps can be an exciting time for investors, but it's essential to understand the dark truth behind these sudden...
Cryptocurrency News: Bitcoin Hits New All-Time High Bitcoin, the world's most famous cryptocurrency, has recently hit a new all-time high....
Investing in the stock market can be an intimidating process, especially when it comes to understanding the ins and outs...
When it comes to the beef market, Big Beef has a pretty tight grip—80% is under the control of just...
If you’re feeling the pinch from your investment in Paragon 28, Inc. (NYSE: FNA) and wondering if there’s a way...
Google is currently facing a significant legal battle in the UK, as a £7 billion class action lawsuit has been...
Google is facing a £7 billion class-action lawsuit in the UK over accusations of abusing its search dominance to harm...
Investors who purchased or acquired securities from The Toronto-Dominion Bank (TD Bank) between February 29, 2024, and October 9, 2024,...